Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.
Most products that stumble post-approval don’t fail on efficacy; they fail because they weren’t built with the market in mind. Our recent webinar, Why the Battle for Future Market Share is Increasingly Won Before Phase 3, brought together experts from across biotech, investment, clinical, and pharma to discuss how to design for adoption, not just approval.
